6-Quinolinecarboxamide, 4,8-dichloro-7-methoxy-
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Lenvatinib Impurity refers to synthetic byproducts or degradants of the tyrosine kinase inhibitor Lenvatinib, utilized primarily for analytical method validation and quality control. The core process involves controlled synthesis to generate specific reference standards. Key parameters include molecular formula <strong>C24H29ClN6O5</strong> and CAS No. <strong>1078397-63-9</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical R&D:</strong> Serving as reference standards for HPLC identification in drug substance characterization.</li>
<li><strong>Quality Assurance:</strong> Employed to validate impurity profiling limits during batch release testing.</li>
<li><strong>Regulatory Compliance:</strong> Supporting stability studies to monitor degradation pathways under ICH guidelines.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly for laboratory research use only; not for human administration. Store in sealed containers at 2-8°C protected from light and moisture to prevent hydrolysis. Personnel must utilize appropriate PPE when handling due to potential cytotoxicity.</p>